SUMMARY Cardiopulmonary bypass (CPB) alters systemic hemodynamics and affects several biochemical systems involved in cardiovascular regulation. We investigated the changes in levels of circulating epinephrine (E) and norepinephrine (NE) and related them to events during CPB. Twenty-eight patients undergoing various surgical procedures were studied. Plasma E and NE were determined by radioenzymatic assay at eight stages of the operation. A ninefold increase in arterial E (from 75 + 13 to 708 ± 117.3 pg/mI) occurred from prebypass (stage 1) measurements to the end of aortic cross-clamping (stage 4). The values at stage 4 were signific'antly higher (p < 0.05) than at all other stages. E decreased rapidly, to 360 84.3 pg/ml, rafter myocardial and pulmonary reperfusion (stage 5). Arterial NE increased twofold from stage 1 to stage 4 (from 426 66.9 to 825 84.2, p < 0.05). The increase in NE from initial CPB values (stage 2) to 30 minutes of aortic cross-clamping (stage 3) was associated with an increase in mean blood pressure (r 0.51, p = 0.02). The peak increases in catecholamines occurred when the heart and lungs were'excluded from the circulation, which suggests that either or both contributed to the increase. Because the increase in E was markedly greater than that in NE, the predominant humoral response to CPB appears to be adrenomedullary release of E. This significant increase in catecholamines could jeopardize myocardial protective measures during'CPB.
MARKED INCREASES in norepinephrine (NE) and epinephrine (E) concentrations in arterial blood during cardiopulmonary bypass (CPB) have been demonstrated. '-' However, no report describes the temporal increase in NE and E in relation to the abnormal hemodynamic and biochemical events during CPB.
Methods

Patients
Twenty-eight adult patients, 10 female and 18 male, scheduled for elective cardiac surgery were studied using a protocol approved by the institutional review board of'the University of Alabama. The operations performed are shown in table 1. All patients continued to take their usual medications, including propranolol, until the time of surgery. Patients taking a methyldopa were excluded from the study. Table 2 contains demographic variables describing the patient population.
Comparison of catecholamines and hemodynamic data from patients with ischemic heart disease (20 patients) and those with combined ischemic and valvular or congenital heart disease revealed no significant alterations in'the response to CPB. Likewise, whether or not patients were taking particular medications (e.g., propranolol or antihypertensive drugs) did not alter the catecholamine or hemodynamic response. Therefore, data from all patients are considered together.
Anesthesia
All patients were anesthetized by the same physician to ensure a consistent anesthetic approach. Anesthetic Circulationn66, No. 1, 19&2. management has been reported in detail elsewhere6 " and consisted of a combinatio'n of diazepam, fentanyl, pancuronium,' nitrous oxide and oxygen, and halothane. Diazepam, 10-15 mg, and pan'curonium, 0.1 mg/kg, were administered at the onset of CPB. No other anesthetic drugs were administered during CPB.
Surgery
All surgery was performed by the same physician to ensure a standardized approach. A pulmonary artery thermistor and right atrial catheter were placed before CPB for determination of cardiac output. A left atrial catheter was placed for continuous monitoring of mean left atrial pressure (LAP), and radial arterial catheters were placed before surgery for continuous measurement of systemic systolic and diastolic arterial pressures. The mean pressure (MBP) was electronically determined. The temperature of the patient was monitored from' the nasopharynx and the arterial perfusate cannula during CPB. The CPB pump (Sarns Model 2000) oxygenator (SpiraFlo BOS-10) was primed with Normosol R (1000 ml) and a solution (1000 ml) of 5% The above measurements were made at eight stages during the operation: (1) during anesthesia just before CPB at normothermia with normal pulsatile cardiac output and the lungs in the circulation; (2) during CPB before aortic cross-clamping at moderate hypothermia (32°C) with pulsatile flow and the lungs in the circulation; (3) 30 minutes after exclusion of heart and lungs from circulation, with hypothermia (28°C) and nonpulsatile flow; (4) 2 minutes after myocardial reperfusion at moderate hypothermia with nonpulsatile flow and lungs excluded from circulation; (5) during pulsatile perfusion with 38°C blood 10 minutes after myocardial and pulmonary reperfusion; (6) 2 minutes after CPB, with conditions similar to those in stage 1; (7) after administration of protamine, with conditions similar to those in stages 1 fusion pressure and changes in NE. The striking mean increase in SVR for all patients during aortic crossclamping paralleled the mean increases in E and NE, but statistical analysis failed to show a significant correlation for individual patients. Therefore, the increases in SVR and MBP during aortic cross-clamping appear to be related to either the cumulative effect of simultaneous increments in NE and E or to other mechanisms, such as increased antidiuretic hormone or activation of the renin-angiotensin system.'9 Continuation of various medications, including propranolol and antihypertensive drugs, until surgery might have interfered with the cardiovascular response to circulating catecholamines. However, when patients taking propranolol and antihypertensive drugs were compared with those who were not, there were no significant differences in hemodynamic responses or patterns of catecholamine release.
A ninefold increase in E and a twofold increase in NE occurred at stage 4, when the lungs and heart were excluded from the circulation. At this time, blood flow was nonpulsatile and hypothermia was most pronounced. Any of these abnormal conditions could in- Although the cause of the striking catecholamine response to CPB cannot be determined from our data, documentation of the temporal rise and fall in circulating catecholamine levels during CPB gives some clues to both the causes and effects of the increased circulating levels of catecholamines. First, the occurrence of peak levels of catecholamines during aortic crossclamping may mean that the exclusion of heart or lung causes or contributes to catecholamine release, perhaps by chemoreceptors located in both organs. Sec SUMMARY Systemic, renal and splanchnic hemodynamics, intravascular volume, circulating catecholamine levels and plasma renin activity were compared in 39 patients with borderline hypertension and 28 normotensive subjects, who were less than 5% (n = 42, lean patients) or more than 40% overweight (n = 25, obese patients). Lean borderline hypertensive patients had greater cardiac output (p < 0.05), heart rate (p < 0.01) and renal blood flow (p < 0.05); cardiopulmonary redistribution of intravascular volume (p < 0.05); and higher circulating norepinephrine levels (p < 0.05). Obese normotensive subjects also showed an increased cardiac output (p < 0.005), stroke volume (p < 0.01), left ventricular stroke work (p < 0.05), and renal blood flow (p < 0.05) (but not respective indexes), but intravascular volume was expanded (p < 0.05) without redistribution and circulating catecholamine levels were normal. Obese borderline hypertensive patients had hemodynamic characteristics similar to those of obese normotensive subjects except for an increased peripheral resistance (p < 0.05). The data indicate that although both populations have an increased cardiac output, the lean borderline hypertensive patients have signs of enhanced adrenergic activity as evidenced by higher circulating catecholamine levels and heart rate with blood volume translocation to the cardiopulmonary circulation. In contrast, the obese subjects (whether normotensive or borderline hypertensive), who also have increased cardiac output, seem 
